Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Product: | Ronapreve |
| Component 1: | |
| Active Ingredient: | Imdevimab 120mg/mL |
| Dosage Form: | Solution for injection |
| Component 2: | |
| Active Ingredient: | Casirivimab 120mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Roche Products (NZ) Limited |
| Manufacturers: | Genentech Inc, Oregon, United States of America Catalent Indiana LLC, Indiana, United States of America |
Dated this 21st day of December 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).